Showing results (81-90 of 631) with videos related to
Sort By:
Pageof 64
The Journal of Laboratory and Clinical Medicine|January 1, 1987
Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamineM Hanss, D CollenArteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
beta-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbitsP Holvoet, D CollenThrombosis and Haemostasis|August 28, 1981
Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitroC Korninger, D CollenDrugs & Aging|January 1, 1996
Optimising thrombolytic therapy in elderly patients with acute myocardial infarctionM Verstraete, D CollenAtherosclerosis|August 7, 1998
Oxidation of low density lipoproteins in the pathogenesis of atherosclerosisP Holvoet, D CollenScandinavian Journal of Clinical and Laboratory Investigation|June 1, 1977
Comparison of the reactions of neutral granulocyte proteases with the major plasma protease inhibitors and with antiplasminK Ohlsson, D CollenJournal of the American College of Cardiology|December 1, 1986
Pharmacology of thrombolytic drugsM Verstraete, D CollenThrombosis and Haemostasis|May 1, 1996
Comparative effects of staphylokinase and alteplase in rabbit bleeding time modelsS Vanderschueren, D CollenThrombosis and Haemostasis|October 1, 1981
Neutralization of human extrinsic (tissue-type) plasminogen activator in human plasma: no evidence for a specific inhibitorC Korninger, D CollenPageof 64